Evaluation and Management of Groin Reactive Lymph Node
For a reactive groin lymph node, observation with clinical monitoring is the standard approach, but fine-needle aspiration (FNA) should be performed if the node is moderately enlarged, heterogeneous on imaging, or persists beyond 4-6 weeks to exclude malignancy. 1, 2
Initial Clinical Assessment
Perform a focused examination evaluating:
- Node characteristics: size (measure diameter), mobility versus fixation, unilateral versus bilateral presentation, and relationship to surrounding structures 3
- Search for primary lesions: examine the lower extremity skin, perineum, genitalia, and anus for potential malignancies or infectious sources 2, 4
- Constitutional symptoms: fever, night sweats, weight loss suggesting systemic disease 2
- Duration of lymphadenopathy: nodes persisting beyond 4-6 weeks warrant tissue diagnosis 5
Critical point: 30-50% of palpable groin lymphadenopathy is inflammatory rather than malignant, so do not assume malignancy without tissue confirmation 2, 4
Diagnostic Algorithm
For Simple Reactive Lymphadenopathy (Small, Mobile, Soft Nodes)
- Treat underlying infection if suspected with appropriate antibiotics 1
- Observe for 4-6 weeks with clinical re-examination 1
- If nodes resolve, no further workup needed 5
For Concerning Features (Enlarged >1.5 cm, Firm, Fixed, or Heterogeneous)
Proceed immediately to FNA as the mandatory first diagnostic step with sensitivity of 91.7% and specificity of 98.2% for detecting malignancy 2
If FNA is negative but clinical suspicion remains high (heterogeneous appearance, persistent enlargement):
- Perform excisional biopsy for definitive diagnosis, as FNA can miss micrometastases 2
If FNA is positive for malignancy:
- Proceed immediately with disease-specific oncologic management 2
- For penile or vulvar cancer: immediate inguinofemoral lymph node dissection 3, 1
- For melanoma: complete lymphadenectomy per melanoma protocols 2
Imaging Considerations
Ultrasound with Doppler is the first-line imaging modality for groin lymph nodes with the following suspicious features: 3, 6, 7
- Longitudinal/transverse diameter ratio <2 (sensitivity 81% for metastasis) 7
- Absent echogenic fatty hilum (specificity 95% for malignancy) 3, 7
- Eccentric or irregular cortex (specificity 96% for malignancy) 7
US-guided FNA should be performed on the largest or most abnormal node if suspicious features are present, increasing diagnostic accuracy to 93% sensitivity and 100% specificity 3
CT or MRI is reserved for:
- Assessment of pelvic lymph nodes when ≥2 positive inguinal nodes are confirmed 4
- Evaluation of primary tumor extent in known malignancy 3
Common Pitfalls to Avoid
Do not proceed to immediate surgical excision without FNA first - this causes unnecessary morbidity and delays diagnosis 2
Do not assume all palpable nodes are malignant - up to 50% are inflammatory, and reactive lymphadenopathy typically resolves spontaneously within weeks 2, 5
Do not miss micrometastases - up to 25% of clinically negative lymph nodes harbor occult metastases in patients with known primary malignancies, emphasizing the importance of pathologic staging 3, 1
Do not delay treatment in confirmed malignancy - subsequent groin relapses after inadequate initial treatment are rarely salvageable 3, 1
Follow-Up Strategy
For confirmed reactive lymphadenopathy:
- Address the underlying infectious or inflammatory cause 2
- Monitor node size and characteristics clinically 1
- Consider repeat biopsy if nodes enlarge, become fixed, or develop concerning features 2
For malignancy: